ArticleFrontiers in nephrology2026
Association of neutrophil-to-lymphocyte-platelet ratio with residual renal function in early-stage peritoneal dialysis patients.
Article in Frontiers in nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To investigate the association between the neutrophil-to-lymphocyte-platelet ratio (NLPR) and residual renal function (RRF) in early-stage peritoneal dialysis (PD) patients, and to evaluate its association with for RRF decline. Methods: This retrospective study included PD patients treated between January 2025 and February 2026. Patients were divided into an early group (dialysis duration 3-12 months) and a late group (>12 months). One extreme NLPR outlier was excluded from the early group, resulting in 23 patients in the early group and 49 in the late group. Spearman's correlation, linear regression, and ROC curve analysis were used. Results: In the early group, NLPR was significantly negatively correlated with residual renal Ccr ( Conclusions: NLPR is significantly associated with RRF in early-stage PD patients. Although it demonstrated good discriminatory ability for RRF status in this cross-sectional study, its predictive value for RRF decline warrants further validation in longitudinal cohort studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.